Fundz

Castle Creek Biosciences, Inc. reported raising $25 Million in an initial SEC Form D filing, from an offering of $25 Million

PRIVATEJul 09, 2021

Amount Raised

$25 Million

$25 Million sold, per SEC Form D (first sale Jul 9, 2021)

Round Type

Venture

ExtonBiotechnologyHealth Care

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Castle Creek Biosciences, Inc that raised within 45 days of this round, from Fundz verified event records.

  • Alucio™ raised $4.2M (Seed) on August 23, 2021.
  • Alucio™ raised an undisclosed amount on August 23, 2021.
  • Penumbra raised $2.7M (Seed) on August 23, 2021.
  • Evecxia raised $8.6M on August 20, 2021.
  • Blackford Analysis raised $687K (Seed) on August 20, 2021.
  • Jnana Therapeutics Inc. raised $50M (Series B) on August 18, 2021.

Who to call at Castle Creek Biosciences, Inc, and when

A new round usually means Castle Creek Biosciences, Inc is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Castle Creek Biosciences, Inc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Castle Creek Biosciences, Inc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Castle Creek Biosciences, Inc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Castle Creek Biosciences, Inc

Location

405 Eagleview Boulevard

Exton, Pennsylvania, United States

About

Castle Creek Biosciences is a late-stage company developing re-dosable gene therapies. It is preparing to launch a pivotal clinical trial of its lead candidate, D-Fi, for patients with dystrophic epidermolysis bullosa (DEB).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Castle Creek Biosciences, Inc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMatthew G., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Castle Creek Biosciences, Inc's next move

See what Strategic adds

Castle Creek Biosciences, Inc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.